Search icon

SENEX BIOTECHNOLOGY, INC.

Company Details

Name: SENEX BIOTECHNOLOGY, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 24 Nov 2003 (21 years ago)
Entity Number: 2981168
ZIP code: 29208
County: Albany
Place of Formation: Delaware
Address: IGOR RONINSON, 715 SUMTER ST, PHARMACY, 513, COLUMBIA, SC, United States, 29208
Principal Address: 715 SUMTER STREET, PHARMACY, RM 513, COLUMBIS, SC, United States, 29208

Chief Executive Officer

Name Role Address
IGOR B RONINSON Chief Executive Officer 715 SUMTER STREET, PHARMACY , RM 513, COLUMBIA, SC, United States, 29208

DOS Process Agent

Name Role Address
THE CORPORATION DOS Process Agent IGOR RONINSON, 715 SUMTER ST, PHARMACY, 513, COLUMBIA, SC, United States, 29208

History

Start date End date Type Value
2009-11-19 2011-12-16 Address 150 NEW SCOTLAND AVENUE, ALBANY, NY, 12208, USA (Type of address: Chief Executive Officer)
2009-11-19 2011-12-16 Address 150 NEW SCOTLAND AVE, ALBANY, NY, 12208, USA (Type of address: Principal Executive Office)
2009-11-19 2011-12-16 Address IGOR RONINSON, 150 NEW SCOTLAND AVE, ALBANY, NY, 12208, USA (Type of address: Service of Process)
2003-11-24 2009-11-19 Address PALMER & DODGE LLP, 111 HUNTINGTON AVE, BOSOTN, MA, 02199, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
111216002303 2011-12-16 BIENNIAL STATEMENT 2011-11-01
091119002321 2009-11-19 BIENNIAL STATEMENT 2009-11-01
031124000646 2003-11-24 APPLICATION OF AUTHORITY 2003-11-24

USAspending Awards. Financial Assistance

FAIN Awarding Agency Assistance Listings Start Date End Date Description
R43CA141845 Department of Health and Human Services 93.395 - CANCER TREATMENT RESEARCH 2009-09-01 2010-08-31 CDK3-INHIBITING ANTICANCER AGENTS
Recipient SENEX BIOTECHNOLOGY INC
Recipient Name Raw SENEX BIOTECHNOLOGY INC
Recipient UEI G8XKMW3DYMQ6
Recipient DUNS 170943240
Recipient Address 150 NEW SCOTLAND AVENUE, ALBANY, ALBANY, NEW YORK, 12208-3425, UNITED STATES
Obligated Amount 107000.00
Non-Federal Funding 0.00
Original Subsidy Cost 0.00
Face Value of Direct Loan 0.00
Link View Page
W81XWH0810611 Department of Defense 12.420 - MILITARY MEDICAL RESEARCH AND DEVELOPMENT 2008-08-15 2009-09-14 BREAST TUMOR GROWTH INHIBITION BY BLOCKING CYTOKINE EXPRESSION IN STROMAL FIBROBLASTS
Recipient SENEX BIOTECHNOLOGY INC
Recipient Name Raw SENEX BIOTECHNOLOGY
Recipient UEI G8XKMW3DYMQ6
Recipient DUNS 170943240
Recipient Address 150 NEW SCOTLAND, ALBANY, ALBANY, NEW YORK, 12208-3425, UNITED STATES
Obligated Amount 90000.00
Non-Federal Funding 0.00
Original Subsidy Cost 0.00
Face Value of Direct Loan 0.00
Link View Page
R43GM081968 Department of Health and Human Services 93.859 - BIOMEDICAL RESEARCH AND RESEARCH TRAINING 2008-02-01 2008-07-31 SMALL MOLECULES INDUCING BTG1 TRANSCRIPTION
Recipient SENEX BIOTECHNOLOGY INC
Recipient Name Raw SENEX BIOTECHNOLOGY INC
Recipient UEI G8XKMW3DYMQ6
Recipient DUNS 170943240
Recipient Address 150 NEW SCOTLAND AVENUE, ALBANY, ALBANY, NEW YORK, 12208
Obligated Amount 107001.00
Non-Federal Funding 0.00
Original Subsidy Cost 0.00
Face Value of Direct Loan 0.00
Link View Page
R44CA139991 Department of Health and Human Services 93.395 - CANCER TREATMENT RESEARCH 2006-08-01 2010-08-31 INHIBITORS OF DISEASE-PROMOTING ACTIVITIES OF SENESCENCE
Recipient SENEX BIOTECHNOLOGY INC
Recipient Name Raw SENEX BIOTECHNOLOGY INC
Recipient UEI G8XKMW3DYMQ6
Recipient DUNS 170943240
Recipient Address 150 NEW SCOTLAND AVENUE, ALBANY, ALBANY, NEW YORK, 12208
Obligated Amount 1002501.00
Non-Federal Funding 0.00
Original Subsidy Cost 0.00
Face Value of Direct Loan 0.00
Link View Page

Date of last update: 22 Feb 2025

Sources: New York Secretary of State